DAVID JOHN GRAINGER - BABRAHAM - PARTNER AT MEDICXI VENTURES (UK) LLP
DAVID JOHN GRAINGER - BABRAHAM - PARTNER AT MEDICXI VENTURES (UK) LLP
.
Overview
DR DAVID JOHN GRAINGER is a Partner At Medicxi Ventures (Uk) Llp from Babraham Cambridgeshire. This person was born in October 1966, which was over 57 years ago. DR DAVID JOHN GRAINGER is British and resident in England. This company officer is, or was, associated with at least 25 company roles.
Their most recent appointment, in our records, was to CRITICAL PRESSURE LIMITED on 2017-10-02, from which they resigned on 2021-11-24.
Address
Babraham Research Campus, C/O The Cambridge Partnership Limited
Babraham
Cambridgeshire
CB22 3AT
England
Map
Company Appointments - Current and Previous
CompanyName | Company Status | Role | Appointed | Appointment Status | Assets |
---|---|---|---|---|---|
CRITICAL PRESSURE LIMITED | Active | Director | 2017-10-02 until 2021-11-24 | RESIGNED | £246,520 cash, £331,277 equity |
DC EUROPA LIMITED | Liquidation | Director | 2017-06-20 | CURRENT | £397,011 cash, £273,680 equity |
THE FOUNDRY (CAMBRIDGE) LIMITED | Active | Director | 2017-06-16 | CURRENT | £34,696 cash, £928,281 equity |
RXBIOLOGICS LIMITED | Active | Director | 2017-03-01 | CURRENT | £247,924 equity |
REBALANCE (CAMBRIDGE) LIMITED | Dissolved - no longer trading | Director | 2016-12-06 | CURRENT | £395,914 cash, £533,987 equity |
CORRECTA4 BIO LIMITED | Dissolved - no longer trading | Director | 2016-04-19 | CURRENT | £190,070 cash, £183,890 equity |
MEDICXI VENTURES (UK) LLP | Active | Llp Member | 2016-01-25 until 2017-12-31 | RESIGNED | |
ULTRAHUMAN LIMITED | Active | Director | 2015-11-24 until 2016-01-19 | RESIGNED | £16,688 cash, £19,343 equity |
SUPERX LIMITED | Dissolved - no longer trading | Director | 2015-11-10 until 2016-01-07 | RESIGNED | £527,235 cash, £778,171 equity |
HUMAN ANTIBODY FACTORY LIMITED | Dissolved - no longer trading | Director | 2015-10-06 | CURRENT | £826,970 cash, £809,702 equity |
ABC MEDICINES LIMITED | Dissolved - no longer trading | Director | 2015-09-15 | CURRENT | £25,077 equity |
CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED | Active | Director | 2015-07-15 until 2021-01-29 | RESIGNED | £3,042,378 cash, £3,578,170 equity |
TOTAL DIAGNOSTICS LIMITED | Dissolved - no longer trading | Director | 2015-03-24 | CURRENT | £1 equity |
STEALTHYX THERAPEUTICS LIMITED | Liquidation | Director | 2014-12-02 until 2017-10-31 | RESIGNED | £121,282 cash, £116,197 equity |
THE CAMBRIDGE PARTNERSHIP LIMITED | Active | Director | 2014-11-01 | CURRENT | £819,020 cash, £805,306 equity |
Z FACTOR LIMITED | Active | Director | 2014-10-21 until 2021-01-29 | RESIGNED | £1,195,577 cash, £1,897,448 equity |
METHUSELAH HEALTH UK LIMITED | Active | Director | 2014-09-09 | CURRENT | £93,121 cash, £-1,234,550 equity |
FUNXIONAL THERAPEUTICS LIMITED | Dissolved - no longer trading | Director | 2014-09-01 | CURRENT | |
APCINTEX LIMITED | Active | Director | 2014-06-16 until 2016-12-07 | RESIGNED | £11,048,377 cash, £11,679,933 equity |
PURPLE PHARMACEUTICALS LIMITED | Dissolved - no longer trading | Director | 2013-07-12 | CURRENT | £76,426 cash, £-246,402 equity |
INHIBITAXIN LIMITED | Dissolved - no longer trading | Director | 2013-06-25 | CURRENT | £2,194 cash, £-596,480 equity |
XO1 LIMITED | Active | Director | 2013-02-28 until 2015-03-18 | RESIGNED | |
ONCOMET LIMITED | Dissolved - no longer trading | Director | 2013-02-28 | CURRENT | |
RXCELERATE LIMITED | Active | Director | 2012-11-07 | CURRENT | £1,883,271 cash, £1,776,249 equity |
TOTAL MEDICAL VENTURES I LLP | Active | Llp Designated Member | 2009-07-23 | CURRENT | £48,918 cash |
Companies Controlled
Company | Active from | Level of control |
---|---|---|
C21MED I LLP | 2018-10-09 |
Voting rights 25 to 50 percent limited liability partnership Right to share surplus assets 25 to 50 percent limited liability partnership Right to appoint and remove members limited liability partnership |
IMHOTEX LIMITED | 2020-02-05 - 2020-03-02 |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
THE FOUNDRY (CAMBRIDGE) LIMITED | 2018-01-01 |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
TOTAL SCIENTIFIC LIMITED | 2016-04-06 - 2018-04-30 |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
HYDROGEN THERAPEUTICS LIMITED | 2019-09-19 - 2020-04-29 |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Related People
Name | Occupation | Address | No of Appointments |
---|---|---|---|
DR ALISTAIR MICHAEL STOKES | Company Executive | Slough | 18 |
DR KEVIN STUART JOHNSON | Company Director | Luton | 7 |
MR FRANCESCO DE RUBERTIS | Venture Capitalist | Altrincham, United Kingdom | 18 |
MR CHRISTIAN DE LA TOUR | Chairman | Slough, United Kingdom | 12 |
DR KONSTANTINOS EFTHYMIOPOULOS | Chief Executive Officer | Cambridge | 2 |
EILEEN JANIS ANDERSON | Director | Aylesbury | 25 |
MICHELE OLLIER | Venture Capitalist | St Albans | 1 |
JASON EDWIN AVERY | Business Executive | Cambridge | 2 |
CALLUM CAMPBELL | Director | Ballsham | 2 |
DR MOUNIA CHAOUI ROULLEAU | Investment Manager | Cambridge, United Kingdom | 1 |
MR MARTIN WILLIAM EDWARDS | Director | Cambridge, England | 2 |
DR DAVID JOHN GRAINGER | Director | Duxford, United Kingdom | 8 |
DR DAVID GRAINGER | Scientist | Duxford | 4 |
DR KARL NAEGLER | Investment Manager | Paris, France | 1 |
DR ROBERT SCHROFF | Pharmaceutical Consultant | Washington, United States Of America | 1 |
DR MICHELE SUSANNE HILL-PERKINS | Senior Technology Transfer Manager | London, England | 2 |
RICHARD WILBECK BUSH | University Official | London | 1 |
MICH??LE OLLIER | Venture Capitalist | 1207 Geneva, Switzerland | 1 |
YUTI CHERNAJOVSKY | Professor Of Rheumatology | London, England | 1 |
Nearby People
Name | Occupation | Address | No of Appointments |
---|---|---|---|
ANDREW SANDHAM | Businessman And Entrepreneur | Cambridge, England | 1 |
DR ANDREW VICTOR GRAHAM MUIR | Fund Manager | Cambridge, England | 14 |
JULIAN MATTHEW SMITH | Cambridge, United Kingdom | 1 | |
KENNETH THOMAS CUNNINGHAM | Director | Cambridge, United Kingdom | 2 |
DR ANKER LUNDEMOSE | Chief Executive Officer | Cambridge | 3 |
MR JULIAN MATTHEW SMITH | Chartered Accountant | Cambridge, United Kingdom | 6 |
MS AMANDA JANE BETTISON | Consultant | Cambridge | 3 |
DR CATHERINE SUSAN MINSHULL BEECH | Director | Cambridge | 5 |
DR ANDREW JOHN MCGLASHAN RICHARDS | Biotechnology Entrepreneur | Cambridge, England | 26 |
MR ROBERT STEVEN JOHNSON | Company Director | Cambridge, England | 7 |